Significats de entered clinical en anglès

Novel therapeutic agents targeting CD70 have entered clinical trials.

More than 75 antiangiogenic compounds have entered clinical trials.

Thus far, Crispr is too new for any somatic cell editing therapy to have entered clinical trials.

Novel biological agents have entered clinical development and pioneering trials have been reported in the last 2 years.

Merck, by contrast, has a keen interest in early products, even those which have not yet entered clinical trials.

Although several FGFR kinase inhibitors have entered clinical trials, single-agent clinical efficacy has been modest and resistance invariably occurs.

To date, numerous novel compounds have entered clinical trials as either single agents or in combination with cytotoxic chemotherapy.

Three inactivated EV71 whole-virus vaccines of different strains developed by different manufacturers in mainland China have recently entered clinical trials.

A growing number of oncolytic viruses has entered clinical investigation or is scheduled to do so in the near future.

Antibody-based therapies, immune checkpoint blockade, cancer vaccines, and chimeric antigen receptor-modified T cells have demonstrated preclinical success and entered clinical testing.

Both sisters entered clinical and epidemiological studies in 1997-studiesthat will help us understand how to use the genetic information we have.

Though none of these inhibitors has reached the market so far, some of them have entered clinical trials and displayed promising results.

Purpose: MET is a potential therapeutic target in lung cancer and both MET tyrosine kinase inhibitors and monoclonal antibodies have entered clinical trials.

As many IGF-IR blockades have been developed, few have been tested preclinically and even fewer have entered clinical trials for prostate cancer therapy.

Although several siRNAs have entered clinical trials, the development of siRNA therapeutics as a new drug class will require the development of improved delivery technologies.

Many of these are still in preclinical development, but several have entered clinical phase I and II trials as monotherapy in patients with relapsed AML.